Wednesday, June 10

Browsing: Mezigdomide

Diagnosis

Mezigdomide Regimen Improves PFS in Pretreated R/R Multiple Myeloma

By NewsCancerMay 30, 20260

At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Paul G. Richardson, MD, of Dana-Farber Cancer Institute in…

Treatments

Mezigdomide Regimen Boosts PFS in Relapsed/Refractory Multiple Myeloma

By NewsCancerMarch 9, 20260

Combining oral mezigdomide with carfilzomib (Kyprolis) and dexamethasone demonstrated a statistically significant and clinically meaningful progression-free survival (PFS) improvement vs…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Asciminib May Offer Longer, Better Life in Frontline CML Care

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Browsing: Mezigdomide

Mezigdomide Regimen Improves PFS in Pretreated R/R Multiple Myeloma

Mezigdomide Regimen Boosts PFS in Relapsed/Refractory Multiple Myeloma

Asciminib May Offer Longer, Better Life in Frontline CML Care

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Actor Tyler Mane reveals he is having treatment for rare male breast cancer | US news

Asciminib May Offer Longer, Better Life in Frontline CML Care

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Actor Tyler Mane reveals he is having treatment for rare male breast cancer | US news

Latest Post

Asciminib May Offer Longer, Better Life in Frontline CML Care

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

How I Stopped Being the Victim of My Own Story

Subscribe to Updates

What's Hot

Browsing: Mezigdomide